8 results
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Overview of various therapies used
chronic obstructive pulmonary ... disease (COPD). ... are approved for clinical ... outcomes or comparison ... #Management #AdvancedCOPD
Noninvasive Positive Pressure Ventilation (NIPPV)

Expiratory & Inspiratory Positive Airway Pressure
Both increase intrathoracic pressure, which can decrease
in obstructive lung ... exacerbation (cardiogenic pulmonary ... hair) • Risk Of Clinical ... intrathoracic damage (pneumothorax ... #criticalcare #management
A-Lines vs B-Lines on Lung POCUS
A-Lines:
 • Predominately horizontal lines
 • A-lines are repeated horizontal &
, asthma, COPD and ... also a pneumothorax ... Commonly seen in pulmonary ... #POCUS #pulmonary ... #clinical #comparison
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... Langerhans giant cells ... characteristic features Clinical ... : Hemoptysis, pneumothorax ... TB #Diagnosis #Management
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
Hepatopulmonary Syndrome ... absence of intrinsic lung ... shunt (Type 2) Clinical ... heart 3-6 cardiac cycles ... on radioactive lung
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... Langerhans giant cells ... characteristic features Clinical ... : Hemoptysis, pneumothorax ... TB #Diagnosis #Management
Sarcoidosis - Diagnosis and Management Summary
Epidemiology
1) High incidence in Scandinavian countries (11-24 cases per 100,000 individuals
Diagnosis and Management ... granulomas within the lungs ... renal failure Clinical ... Pulmonary: dyspnea ... acute sarcoidosis Pulmonary
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
ducts Clinical ... Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... MALT Lymphoma • Lung ... Rheumatology #Diagnosis #Management